How do glucocorticoids, biologic disease – modifying anti- rheumatic drugs and disease activity impact the risk of staphylococcus aureus bacteremia in rheumatoid arthritis patients? A nationwide nested case control study in the Danish DANBIO cohort: A nationwide nested case control study in the Danish DANBIO cohort

Sabine Sparre  Dieperink; Bente Glintborg; F. Mehnert; Mia Nørgaard; Thomas Benfield; Christian  Torp-Pedersen; Louise Bruun Oestergaard; A Petersen; Merete Lund Hetland

How do glucocorticoids, biologic disease – modifying anti- rheumatic drugs and disease activity impact the risk of staphylococcus aureus bacteremia in rheumatoid arthritis patients? A nationwide nested case control study in the Danish DANBIO cohort: A nationwide nested case control study in the Danish DANBIO cohort

Sabine Sparre Dieperink, Bente Glintborg, F. Mehnert, Mia Nørgaard, Thomas Benfield, Christian Torp-Pedersen, Louise Bruun Oestergaard, A Petersen, Merete Lund Hetland

Original language	English
Publication date	2022
Publication status	Published - 2022
Event	EULAR 2022 - Copenhagen Duration: 1 Jun 2022 → 4 Jun 2022

Conference

Conference	EULAR 2022
City	Copenhagen
Period	01/06/2022 → 04/06/2022

Cite this

Dieperink, S. S., Glintborg, B., Mehnert, F., Nørgaard, M., Benfield, T., Torp-Pedersen, C., Oestergaard, L. B., Petersen, A., & Hetland, M. L. (2022). How do glucocorticoids, biologic disease – modifying anti- rheumatic drugs and disease activity impact the risk of staphylococcus aureus bacteremia in rheumatoid arthritis patients? A nationwide nested case control study in the Danish DANBIO cohort: A nationwide nested case control study in the Danish DANBIO cohort. Annals of the Rheumatic Diseases 81: 571. Abstract from EULAR 2022, Copenhagen.

How do glucocorticoids, biologic disease – modifying anti- rheumatic drugs and disease activity impact the risk of staphylococcus aureus bacteremia in rheumatoid arthritis patients? A nationwide nested case control study in the Danish DANBIO cohort: A nationwide nested case control study in the Danish DANBIO cohort. / Dieperink, Sabine Sparre ; Glintborg, Bente; Mehnert, F. et al.
2022. Annals of the Rheumatic Diseases 81: 571 Abstract from EULAR 2022, Copenhagen.

Research output: Contribution to conference › Conference abstract for conference › Research › peer-review

Dieperink, SS , Glintborg, B, Mehnert, F, Nørgaard, M, Benfield, T , Torp-Pedersen, C, Oestergaard, LB, Petersen, A & Hetland, ML 2022, 'How do glucocorticoids, biologic disease – modifying anti- rheumatic drugs and disease activity impact the risk of staphylococcus aureus bacteremia in rheumatoid arthritis patients? A nationwide nested case control study in the Danish DANBIO cohort: A nationwide nested case control study in the Danish DANBIO cohort', EULAR 2022, Copenhagen, 01/06/2022 - 04/06/2022 pp. Annals of the Rheumatic Diseases 81: 571.

Dieperink SS , Glintborg B, Mehnert F, Nørgaard M, Benfield T , Torp-Pedersen C et al.. How do glucocorticoids, biologic disease – modifying anti- rheumatic drugs and disease activity impact the risk of staphylococcus aureus bacteremia in rheumatoid arthritis patients? A nationwide nested case control study in the Danish DANBIO cohort: A nationwide nested case control study in the Danish DANBIO cohort. 2022. Abstract from EULAR 2022, Copenhagen.

Dieperink, Sabine Sparre ; Glintborg, Bente ; Mehnert, F. et al. / How do glucocorticoids, biologic disease – modifying anti- rheumatic drugs and disease activity impact the risk of staphylococcus aureus bacteremia in rheumatoid arthritis patients? A nationwide nested case control study in the Danish DANBIO cohort : A nationwide nested case control study in the Danish DANBIO cohort. Abstract from EULAR 2022, Copenhagen.

@conference{5693ff3cdb50472cb0e87939b53c3e8c,

title = "How do glucocorticoids, biologic disease – modifying anti- rheumatic drugs and disease activity impact the risk of staphylococcus aureus bacteremia in rheumatoid arthritis patients? A nationwide nested case control study in the Danish DANBIO cohort: A nationwide nested case control study in the Danish DANBIO cohort",

author = "Dieperink, {Sabine Sparre} and Bente Glintborg and F. Mehnert and Mia N{\o}rgaard and Thomas Benfield and Christian Torp-Pedersen and Oestergaard, {Louise Bruun} and A Petersen and Hetland, {Merete Lund}",

note = "COPECARE; EULAR 2022 ; Conference date: 01-06-2022 Through 04-06-2022",

year = "2022",

language = "English",

pages = "Annals of the Rheumatic Diseases 81: 571",

}

TY - ABST

T1 - How do glucocorticoids, biologic disease – modifying anti- rheumatic drugs and disease activity impact the risk of staphylococcus aureus bacteremia in rheumatoid arthritis patients? A nationwide nested case control study in the Danish DANBIO cohort

T2 - EULAR 2022

AU - Dieperink, Sabine Sparre

AU - Glintborg, Bente

AU - Mehnert, F.

AU - Nørgaard, Mia

AU - Benfield, Thomas

AU - Torp-Pedersen, Christian

AU - Oestergaard, Louise Bruun

AU - Petersen, A

AU - Hetland, Merete Lund

N1 - COPECARE

PY - 2022

Y1 - 2022

M3 - Conference abstract for conference

SP - Annals of the Rheumatic Diseases 81: 571

Y2 - 1 June 2022 through 4 June 2022

ER -